Abiopharma

Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production

NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control

X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering

General Announcement: ISSUANCE OF SHARES PURSUANT TO EXERCISE OF WARRANTS

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Director Xia Yu 🟢 acquired 533.6K shares of Summit Therapeutics Inc. (SMMT) at $18.74 ($10.0M) Transaction Date: Oct 21, 2025 | Filing ID: 000004

Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma

QuidelOrtho Corporation - Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

ResMed Inc. Daily Stock Update

Healthy Extracts’ Gummy USA Secures 6 Million Gummy Follow-On Order from Woman’s Health Nutraceutical Leader

Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025

Blackstone i TPG przejmą Hologic za kwotę 79 USD za akcję

Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights